PatchSiren cyber security CVE debrief
CVE-2026-100560 OpenClaw CVE debrief
OpenClaw versions before 2026.8.1 contain an authorization bypass vulnerability where Allow Always approvals for exact commands persist as path-only grants on macOS and Linux. Attackers can reuse the same executable with different arguments to execute commands without triggering new approval prompts, potentially accessing files or internal services.
- Vendor
- OpenClaw
- Product
- Unknown
- CVSS
- HIGH 7.7
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-09-26
- Original CVE updated
- 2026-09-26
- Advisory published
- 2026-09-26
- Advisory updated
- 2026-09-26
Who should care
Defenders responsible for OpenClaw deployments on macOS and Linux should assess exposure and prioritize verification and remediation. This includes reviewing system configurations, user permissions, and executable permissions to prevent potential exploitation. Additionally, defenders should consider implementing compensating controls, such as restricting access to sensitive files and internal services, and monitoring for suspicious command executions.
Why it matters
The CVE-2026-100560 authorization bypass vulnerability in OpenClaw versions before 2026.8.1 requires verification and remediation to prevent potential exploitation and impacts on macOS and Linux deployments.
- Defenders must verify OpenClaw versions and upgrade to 2026.8.1 or later to prevent exploitation
- Restricting executable permissions and monitoring for suspicious command executions can help mitigate potential impacts
- The vulnerability allows attackers to execute commands without triggering new approval prompts, potentially accessing files or internal services
Technical summary
OpenClaw versions before 2026.8.1 contain an authorization bypass vulnerability where Allow Always approvals for exact commands persist as path-only grants on macOS and Linux. Attackers can reuse the same executable with different arguments to execute commands without triggering new approval prompts, potentially accessing files or internal services. This vulnerability requires verification and remediation to prevent potential exploitation and impacts on macOS and Linux deployments. Defenders should prioritize verifying OpenClaw versions and upgrading to 2026.8.1 or later.
Defensive priority
Defenders should prioritize verifying OpenClaw versions and upgrading to 2026.8.1 or later. They should also review and restrict executable permissions and monitor for suspicious command executions.
Recommended defensive actions
- Verify OpenClaw versions and upgrade to 2026.8.1 or later
- Review and restrict executable permissions
- Monitor for suspicious command executions
- Perform vulnerability scanning to identify potentially exposed systems
- Implement additional logging and monitoring to detect potential exploitation attempts
- Conduct a thorough review of system configurations and user permissions
- Develop and deploy a patch management process to ensure timely updates
Evidence notes
The CVE record and NVD entry provide details on the authorization bypass vulnerability in OpenClaw versions before 2026.8.1. However, the corpus does not establish versions, exploitation, impact, or remediation beyond upgrading to 2026.8.1 or later.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-100560 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-100560
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-100560 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-100560
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://github.com/openclaw/openclaw/security/advisories/GHSA-74gc-hg2m-79p9
-
Source reference
Unverified legacy reference
URL: https://www.vulncheck.com/advisories/openclaw-before-2026.8.1-reusable-exec-approvals-authorization-bypass
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.